Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1ε in addition to MULT-1 and H60

Molecular Immunology

Volumn 47, Issue 1, 2009, Pages 114-122

  Arapović, Jurica ^a   Lenac Roviš, Tihana ^a   Reddy, Anil Butchi ^a   Krmpotić, Astrid ^a   Jonjić, Stipan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Immunoevasion; Mouse cytomegalovirus; NK cells; NKG2D; RAE 1

Indexed keywords

IMMUNOEVASIN; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN H60; PROTEIN M138; PROTEIN M145; PROTEIN M152; PROTEIN M155; PROTEIN MULT 1; PROTEIN RAE 1EPSILON; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL STRAIN 3T3; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; ENDOCYTOSIS; FIBROBLAST; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS;

ANIMALS; CARRIER PROTEINS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, FC; VIRAL PROTEINS;

CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS;

EID: 70350418637     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.02.010     Document Type: Article

References (41)

1. Alcami A., and Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today 21 (2000) 447-455
2. Brune W., Hengel H., and Koszinowski U.H. A mouse model for cytomegalovirus infection. Current Protocols in Immunology vol. 4 (1999), John Wiley & Sons., New York pp. 19.7.1-19.7.13.
3. Brune W., Wagner M., and Messerle M. Manipulating cytomegalovirus genomes by BAC mutagenesis: strategies and applications. In: Reddehase M.J. (Ed). Cytomegaloviruses: Molecular Biology and Immunology vol. 1 (2006), Caister Academic Press, Wymondham, Norfolk 63-89
4. Carayannopoulos L.N., Naidenko O.V., Kinder J., Ho E.L., Fremont D.H., and Yokoyama W.M. Ligands for murine NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 32 (2002) 597-605
5. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., and Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 (2000) 721-727
6. Chalupny N.J., Rein-Weston A., Dosch S., and Cosman D. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346 (2006) 175-181
7. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., and Koszinowski U.H. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72 (1998) 1377-1382
8. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C., and Cosman D. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197 (2003) 1427-1439
9. Groh V., Smythe K., Dai Z., and Spies T. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 7 (2006) 755-762
10. Hamerman J.A., Ogasawara K., and Lanier L.L. Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172 (2004) 2001-2005
11. Hasan M., Krmpotic A., Ruzsics Z., Bubic I., Lenac T., Halenius A., Loewendorf A., Messerle M., Hengel H., Jonjic S., and Koszinowski U.H. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol. 79 (2005) 2920-2930
12. Henry J., Miller M.M., and Pontarotti P. Structure and evolution of the extended B7 family. Immunol. Today 20 (1999) 285-288
13. Jonjic S., Babic M., Polic B., and Krmpotic A. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20 (2008) 30-38
14. Jonjic S., Bubic I., and Krmpotic A. Innate immunity to cytomegaloviruses. In: Reddehase M.J. (Ed). Cytomegaloviruses: Molecular Biology and Immunology (2006), Caister Academic Press, Wymondham, Norfolk 285-319
15. Jonjic S., Krmpotic A., Arapovic J., and Koszinowski U.H. Dissection of the antiviral NK cell response by MCMV mutants. Methods Mol. Biol. 415 (2008) 127-149
16. Krmpotic A., Busch D.H., Bubic I., Gebhardt F., Hengel H., Hasan M., Scalzo A.A., Koszinowski U.H., and Jonjic S. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3 (2002) 529-535
17. Krmpotic A., Hasan M., Loewendorf A., Saulig T., Halenius A., Lenac T., Polic B., Bubic I., Kriegeskorte A., Pernjak-Pugel E., Messerle M., Hengel H., Busch D.H., Koszinowski U.H., and Jonjic S. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201 (2005) 211-220
18. Krmpotic A., Messerle M., Crnkovic-Mertens I., Polic B., Jonjic S., and Koszinowski U.H. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190 (1999) 1285-1296
19. Lenac T., Arapovic J., Traven L., Krmpotic A., and Jonjic S. Murine cytomegalovirus regulation of NKG2D ligands. Med. Microbiol. Immunol. 197 (2008) 159-166
20. Lenac T., Budt M., Arapovic J., Hasan M., Zimmermann A., Simic H., Krmpotic A., Messerle M., Ruzsics Z., Koszinowski U.H., Hengel H., and Jonjic S. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203 (2006) 1843-1850
21. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., and Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197 (2003) 1245-1253
22. Lodoen M.B., Abenes G., Umamoto S., Houchins J.P., Liu F., and Lanier L.L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200 (2004) 1075-1081
23. Loewendorf A., Kruger C., Borst E.M., Wagner M., Just U., and Messerle M. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78 (2004) 13062-13071
24. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., and Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10 (2006) 839-850
25. Mintern J.D., Klemm E.J., Wagner M., Paquet M.E., Napier M.D., Kim Y.M., Koszinowski U.H., and Ploegh H.L. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J. Immunol. 177 (2006) 8422-8431
26. Mocarski E.S., and Courcelle C.T. Cytomegaloviruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia 2629-2674
27. Ohe Y., Zhao D., Saijo N., and Podack E.R. Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum. Gene Ther. 6 (1995) 325-333
28. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5 (2004) 996-1002
29. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., and Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. Embo J. 18 (1999) 1081-1091
30. Rolle A., Mousavi-Jazi M., Eriksson M., Odeberg J., Soderberg-Naucler C., Cosman D., Karre K., and Cerboni C. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J. Immunol. 171 (2003) 902-908
31. Schlicht H.J., and Schaller H. The secretory core protein of human hepatitis B virus is expressed on the cell surface. J. Virol. 63 (1989) 5399-5404
32. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D.G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D., Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., and Mandelboim O. Host immune system gene targeting by a viral miRNA. Science 317 (2007) 376-381
33. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., and Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 9 (2008) 1065-1073
34. Thäle R., Lucin P., Schneider K., Eggers M., and Koszinowski U.H. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68 (1994) 7757-7765
35. Wagner M., Gutermann A., Podlech J., Reddehase M.J., and Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196 (2002) 805-816
36. Wagner M., Jonjic S., Koszinowski U.H., and Messerle M. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73 (1999) 7056-7060
37. Welte S.A., Sinzger C., Lutz S.Z., Singh-Jasuja H., Sampaio K.L., Eknigk U., Rammensee H.G., and Steinle A. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33 (2003) 194-203
38. Wilkinson G.W., Tomasec P., Stanton R.J., Armstrong M., Prod'homme V., Aicheler R., McSharry B.P., Rickards C.R., Cochrane D., Llewellyn-Lacey S., Wang E.C., Griffin C.A., and Davison A.J. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41 (2008) 206-212
39. Wu J., Chalupny N.J., Manley T.J., Riddell S.R., Cosman D., and Spies T. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol. 170 (2003) 4196-4200
40. Ziegler H., Muranyi W., Burgert H.G., Kremmer E., and Koszinowski U.H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. Embo J. 19 (2000) 870-881
41. Ziegler H., Thäle R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., and Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6 (1997) 57-66